✦ LIBER ✦

Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE II study

✍ Scribed by Marc Cohen; Pierre Théroux; Steven Borzak; Martin J. Frey; Harvey D. White; W. Van Mieghem; Fred Senatore; Joy Lis; Robin Mukherjee; Kathy Harris; Frederique Bigonzi

Book ID: 117842949
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 115 KB
Volume: 144
Category: Article
ISSN: 1097-6744
DOI: 10.1067/mhj.2002.126115

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of enoxaparin vs. un

Safety and efficacy of enoxaparin vs. unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes. who receive tirofiban and aspirin

✍ M.A. Blazing; J.A. de Lemos; H.D. White 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Safety and Efficacy of Enoxaparin vs Unf

Safety and Efficacy of Enoxaparin vs Unfractionated Heparin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Who Receive Tirofiban and AspirinA Randomized Controlled Trial

✍ Blazing, Michael A. 📂 Article 📅 2004 🏛 American Medical Association 🌐 English ⚖ 180 KB

Fondaparinux with UnfracTionated heparin

Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): A randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux

✍ Philippe Gabriel Steg; Shamir Mehta; Sanjit Jolly; Denis Xavier; Hans-Juergen Ru 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 195 KB

PCV49 ENOXAPARIN VERSUS UNFRACTIONATED H

PCV49 ENOXAPARIN VERSUS UNFRACTIONATED HEPARIN FOR THE NONINVASIVE MANAGEMENT OF PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES (NSTE-ACS): THE PHARMACOECONOMIC EVALUATION IN RUSSIA

✍ A Syrov; S Zyryanov; YB Belousov 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Comparison of Effectiveness of Enoxapari

Comparison of Effectiveness of Enoxaparin Versus Unfractionated Heparin to Reduce Silent and Clinically Apparent Acute Myocardial Infarction in Patients Presenting With Non–ST-Segment Elevation Acute Coronary Syndrome

✍ Sanjit Jolly; Mary Tan; Aurora Mendelsohn; David Fitchett; Paul W. Armstrong; An 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Randomized evaluation of the safety and

Randomized evaluation of the safety and efficacy of enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide

✍ S.G. Goodman; D. Fitchett; P.W. Armstrong; M. Tan; A. Langer 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 41 KB